Novo Nordisk (NVO) is offering a unique opportunity for investors who may have missed out during its earlier surge, with the ...

Amgen stock tumbled late Tuesday on a report that its high-profile weight-loss shot, MariTide, could be linked to bone ...

Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, ...

Each stock is given an alphabetic rating of A ... Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Bagsværd, Denmark-based Novo Nordisk is a global healthcare ...

Novo Nordisk’s practices have raised red flags in Denmark as ... Regardless, investors are much more concerned with future ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

(Reuters) - European shares opened higher on Monday with most sectors rising, kicking off a week packed with global economic ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), the kings of the titanic weight-loss drugs market, might have a problem on their hands. After reporting their third-quarter earnings, shares of both ...